首页> 美国卫生研究院文献>Human Gene Therapy Methods >Copackaging of Multiple Adeno-Associated Viral Vectors in a Single Production Step
【2h】

Copackaging of Multiple Adeno-Associated Viral Vectors in a Single Production Step

机译:在单个生产步骤中多个腺相关病毒载体的共包装

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Limiting factors in large preclinical and clinical studies utilizing adeno-associated virus (AAV) for gene therapy are focused on the restrictive packaging capacity, the overall yields, and the versatility of the production methods for single AAV vector production. Furthermore, applications where multiple vectors are needed to provide long expression cassettes, whether because of long cDNA sequences or the need of different regulatory elements, require that each vector be packaged and characterized separately, directly affecting labor and cost associated with such manufacturing strategies. To overcome these limitations, we propose a novel method of vector production that allows for the packaging of multiple expression cassettes in a single transfection step. Here we combined two expression cassettes in predetermined ratios before transfection and empirically demonstrate that the output vector recapitulates the predicted ratios. Titration by quantitative polymerase chain reaction of AAV vector genome copies using shared or unique genetic elements allowed for delineation of the individual vector contribution to the total preparation that showed the predicted differential packaging outcomes. By copackaging green fluorescent protein (GFP) and mCherry constructs, we demonstrate that both vector genome and infectious titers reiterated the ratios utilized to produce the constructs by transfection. Copackaged therapeutic constructs that only differ in transcriptional elements produced a heterogeneous vector population of both constructs in the predefined ratios. This study shows feasibility and reproducibility of a method that allows for two constructs, differing in either transgene or transcription elements, to be efficiently copackaged and characterized simultaneously, reducing cost of manufacturing and release testing.
机译:在大型临床前和临床研究中,使用腺相关病毒(AAV)进行基因治疗的限制因素集中在限制性包装能力,总产量以及单一AAV载体生产的生产方法的多功能性上。此外,由于长的cDNA序列或需要不同的调控元件而需要多个载体来提供长表达盒的应用要求将每个载体分别包装和表征,直接影响与这种制备策略相关的人工和成本。为了克服这些限制,我们提出了一种新颖的载体生产方法,该方法允许在单个转染步骤中包装多个表达盒。在这里,我们在转染前以预定比例组合了两个表达盒,并凭经验证明了输出载体概括了预测比例。使用共享或独特的遗传元件通过AAV载体基因组拷贝的定量聚合酶链反应进行滴定,可以描绘出单个载体对总制剂的贡献,该总制剂显示了预期的差异包装结果。通过共同包装绿色荧光蛋白(GFP)和mCherry构建体,我们证明了载体基因组和感染滴度均重申了用于通过转染生产构建体的比率。仅在转录元件上不同的共包装的治疗性构建体以预定的比例产生了两种构建体的异质载体群体。这项研究显示了一种方法的可行性和可重复性,该方法可以使转基因或转录元件不同的两种构建体同时有效地共同包装和表征,从而降低制造和发布测试的成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号